Clinical Trial Details

EORTC-1508-GCG

Back to Clinical Trials Database

A phase II study of the anti-PD-L1 antibody atezolizumab, bevacizumab and acetylsalicylic acid to investigate safety and efficacy of this combination in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 21-Dec-2016
Date Step1 close: 11-Mar-2020
Date Step2 close: 11-Mar-2020
Data management at EORTC Yes
Design Phase 2
Randomized blind
Targeted Sample size EORTC Groups: 160 - All Groups: 160
Treatment Drug
Bevacizumab, Atezolizumab, Acetylsalicylic acid, Acetylsalicylic acid / placebo
Study Staff Susana Banerjee (Study Coordinator) , Royal Marsden Hospital - Chelsea, London, London
George Coukos (Study Coordinator) , Centre Hospitalier Universitaire Vaudois - Lausanne, Lausanne
Jose Casas (TR Scientist) , EORTC Headquarters, Brussels
Corneel Coens (Statistician) , EORTC Headquarters, Brussels
Ilse Coppens (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
David Ndah Aki (Clinical Operations Manager) , EORTC Headquarters, Brussels
Gilles Sarlet (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Egle Venslovaite (Project Manager) , EORTC Headquarters, Brussels
Type of cancer Fallopian Tube
Ovarian
Participating groups EORTC Gynecological Cancer Group
Recruiting centers APHP Centre - Univ de Paris Cite - Hoptial Europeen Georges Pompidou (PARIS, France)
Centre Hospitalier Prive Saint-Gregoire (Saint-Gregoire, France)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Clinique Pasteur-Lanroze (BREST, France)
Guy s and St Thomas' NHS - Guy's Hospital (London, United Kingdom)
Hospital Universitario San Carlos (Madrid, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
Leiden University Medical Centre (Leiden, Netherlands)
Radboud University Medical Center Nijmegen (Nijmegen, Netherlands)
Royal Marsden Hospital - Chelsea, London (London, United Kingdom)
Royal Marsden Hospital - Sutton, Surrey (Surrey, United Kingdom)
Protocol summary http://clinicaltrials.gov/study/NCT02659384
NCT number NCT02659384
EudraCT 2015-004601-17
Financial Support Educational Grant